Annual FCF
-$50.48 M
+$2.04 M+3.88%
30 June 2024
Summary:
MEI Pharma annual free cash flow is currently -$50.48 million, with the most recent change of +$2.04 million (+3.88%) on 30 June 2024. During the last 3 years, it has fallen by -$17.81 million (-54.51%). MEIP annual FCF is now -251.30% below its all-time high of $33.36 million, reached on 30 June 2020.MEIP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$11.45 M
+$6.55 M+36.39%
30 September 2024
Summary:
MEI Pharma quarterly free cash flow is currently -$11.45 million, with the most recent change of +$6.55 million (+36.39%) on 30 September 2024. Over the past year, it has increased by +$7.04 million (+38.08%). MEIP quarterly FCF is now -116.59% below its all-time high of $69.00 million, reached on 30 June 2020.MEIP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$43.44 M
+$7.04 M+13.95%
30 September 2024
Summary:
MEI Pharma TTM free cash flow is currently -$43.44 million, with the most recent change of +$7.04 million (+13.95%) on 30 September 2024. Over the past year, it has increased by +$12.73 million (+22.66%). MEIP TTM FCF is now -183.27% below its all-time high of $52.17 million, reached on 31 December 2020.MEIP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +38.1% | +22.7% |
| 3 y3 years | -54.5% | -48.1% | -41.7% |
| 5 y5 years | -70.3% | +18.7% | -40.6% |
MEIP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -54.5% | +3.9% | -291.1% | +38.1% | -41.7% | +29.9% |
| 5 y | 5 years | -251.3% | +3.9% | -116.6% | +38.1% | -183.3% | +29.9% |
| alltime | all time | -251.3% | +3.9% | -116.6% | +38.1% | -183.3% | +29.9% |
MEI Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.45 M(-36.4%) | -$43.44 M(-13.9%) |
| June 2024 | -$50.48 M(-3.9%) | -$18.00 M(+514.7%) | -$50.48 M(+15.2%) |
| Mar 2024 | - | -$2.93 M(-73.5%) | -$43.82 M(-17.4%) |
| Dec 2023 | - | -$11.06 M(-40.2%) | -$53.02 M(-5.6%) |
| Sept 2023 | - | -$18.49 M(+63.1%) | -$56.16 M(+6.9%) |
| June 2023 | -$52.52 M(+6.7%) | -$11.34 M(-6.5%) | -$52.52 M(-7.8%) |
| Mar 2023 | - | -$12.13 M(-14.6%) | -$56.99 M(-8.0%) |
| Dec 2022 | - | -$14.21 M(-4.3%) | -$61.93 M(+9.9%) |
| Sept 2022 | - | -$14.85 M(-6.1%) | -$56.34 M(+14.5%) |
| June 2022 | -$49.23 M(+50.7%) | -$15.81 M(-7.4%) | -$49.23 M(+10.2%) |
| Mar 2022 | - | -$17.07 M(+98.1%) | -$44.68 M(+3.3%) |
| Dec 2021 | - | -$8.62 M(+11.5%) | -$43.26 M(+41.2%) |
| Sept 2021 | - | -$7.73 M(-31.4%) | -$30.65 M(-6.2%) |
| June 2021 | -$32.67 M(-197.9%) | -$11.27 M(-28.0%) | -$32.67 M(-168.6%) |
| Mar 2021 | - | -$15.65 M(-491.7%) | $47.60 M(-8.8%) |
| Dec 2020 | - | $3.99 M(-140.9%) | $52.17 M(+38.4%) |
| Sept 2020 | - | -$9.76 M(-114.1%) | $37.69 M(+13.0%) |
| June 2020 | $33.36 M(-212.6%) | $69.00 M(-723.1%) | $33.36 M(-176.3%) |
| Mar 2020 | - | -$11.07 M(+5.6%) | -$43.71 M(-0.7%) |
| Dec 2019 | - | -$10.49 M(-25.5%) | -$44.02 M(+42.4%) |
| Sept 2019 | - | -$14.08 M(+74.4%) | -$30.90 M(+4.3%) |
| June 2019 | -$29.64 M(+40.9%) | -$8.07 M(-29.0%) | -$29.64 M(+18.3%) |
| Mar 2019 | - | -$11.38 M(-533.1%) | -$25.05 M(+25.8%) |
| Dec 2018 | - | $2.63 M(-120.5%) | -$19.91 M(-27.0%) |
| Sept 2018 | - | -$12.82 M(+268.0%) | -$27.29 M(+29.7%) |
| June 2018 | -$21.04 M(-712.4%) | -$3.48 M(-44.2%) | -$21.04 M(+1.4%) |
| Mar 2018 | - | -$6.24 M(+31.3%) | -$20.75 M(+60.8%) |
| Dec 2017 | - | -$4.75 M(-27.6%) | -$12.90 M(+8.4%) |
| Sept 2017 | - | -$6.56 M(+105.4%) | -$11.90 M(-446.4%) |
| June 2017 | $3.44 M(-119.2%) | -$3.19 M(-298.9%) | $3.44 M(+9.2%) |
| Mar 2017 | - | $1.61 M(-142.9%) | $3.15 M(-210.5%) |
| Dec 2016 | - | -$3.75 M(-142.7%) | -$2.85 M(-14.4%) |
| Sept 2016 | - | $8.77 M(-351.8%) | -$3.33 M(-81.4%) |
| June 2016 | -$17.86 M(-36.4%) | -$3.48 M(-20.6%) | -$17.86 M(-15.4%) |
| Mar 2016 | - | -$4.39 M(+3.8%) | -$21.12 M(-15.1%) |
| Dec 2015 | - | -$4.23 M(-26.6%) | -$24.88 M(-8.2%) |
| Sept 2015 | - | -$5.76 M(-14.5%) | -$27.11 M(-3.5%) |
| June 2015 | -$28.08 M(+44.0%) | -$6.74 M(-17.3%) | -$28.08 M(+3.2%) |
| Mar 2015 | - | -$8.15 M(+26.3%) | -$27.22 M(+12.7%) |
| Dec 2014 | - | -$6.46 M(-4.1%) | -$24.16 M(+9.0%) |
| Sept 2014 | - | -$6.73 M(+14.5%) | -$22.16 M(+13.7%) |
| June 2014 | -$19.50 M | -$5.88 M(+15.6%) | -$19.50 M(+18.9%) |
| Mar 2014 | - | -$5.09 M(+13.9%) | -$16.40 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | -$4.47 M(+9.8%) | -$13.97 M(+19.8%) |
| Sept 2013 | - | -$4.07 M(+46.6%) | -$11.66 M(+15.7%) |
| June 2013 | -$10.08 M(+42.4%) | -$2.78 M(+4.6%) | -$10.08 M(+17.1%) |
| Mar 2013 | - | -$2.65 M(+22.8%) | -$8.61 M(+4.6%) |
| Dec 2012 | - | -$2.16 M(-13.1%) | -$8.23 M(+4.9%) |
| Sept 2012 | - | -$2.49 M(+90.9%) | -$7.84 M(+10.7%) |
| June 2012 | -$7.08 M(+8.1%) | -$1.30 M(-42.6%) | -$7.08 M(-4.5%) |
| Mar 2012 | - | -$2.27 M(+28.1%) | -$7.41 M(+8.2%) |
| Dec 2011 | - | -$1.77 M(+2.5%) | -$6.85 M(+1.8%) |
| Sept 2011 | - | -$1.73 M(+5.9%) | -$6.73 M(+2.7%) |
| June 2011 | -$6.55 M(-34.7%) | -$1.63 M(-4.5%) | -$6.55 M(-9.3%) |
| Mar 2011 | - | -$1.71 M(+3.6%) | -$7.22 M(+3.4%) |
| Dec 2010 | - | -$1.65 M(+6.4%) | -$6.98 M(-9.9%) |
| Sept 2010 | - | -$1.55 M(-32.7%) | -$7.75 M(-22.7%) |
| June 2010 | -$10.04 M(-4.9%) | -$2.31 M(+56.6%) | -$10.03 M(-15.1%) |
| Mar 2010 | - | -$1.47 M(-39.1%) | -$11.81 M(-3.0%) |
| Dec 2009 | - | -$2.42 M(-36.9%) | -$12.18 M(+4.4%) |
| Sept 2009 | - | -$3.83 M(-6.1%) | -$11.66 M(+10.5%) |
| June 2009 | -$10.55 M(-8.2%) | -$4.08 M(+122.4%) | -$10.55 M(+10.3%) |
| Mar 2009 | - | -$1.84 M(-3.6%) | -$9.57 M(-15.7%) |
| Dec 2008 | - | -$1.91 M(-30.1%) | -$11.35 M(-3.7%) |
| Sept 2008 | - | -$2.73 M(-12.1%) | -$11.79 M(+2.6%) |
| June 2008 | -$11.50 M(+6.6%) | -$3.10 M(-14.3%) | -$11.50 M(+9.7%) |
| Mar 2008 | - | -$3.62 M(+54.0%) | -$10.48 M(+19.4%) |
| Dec 2007 | - | -$2.35 M(-3.5%) | -$8.78 M(+23.7%) |
| Sept 2007 | - | -$2.43 M(+16.5%) | -$7.10 M(-34.2%) |
| June 2007 | -$10.79 M(+18.7%) | -$2.09 M(+9.2%) | -$10.79 M(-5.5%) |
| Mar 2007 | - | -$1.91 M(+188.0%) | -$11.41 M(-20.6%) |
| Dec 2006 | - | -$664.00 K(-89.2%) | -$14.37 M(-0.2%) |
| Sept 2006 | - | -$6.12 M(+125.6%) | -$14.39 M(+58.4%) |
| June 2006 | -$9.09 M(+62.9%) | -$2.71 M(-44.3%) | -$9.09 M(+23.4%) |
| Mar 2006 | - | -$4.87 M(+609.2%) | -$7.37 M(+37.2%) |
| Dec 2005 | - | -$687.00 K(-15.8%) | -$5.37 M(+0.2%) |
| Sept 2005 | - | -$816.00 K(-17.8%) | -$5.36 M(-4.0%) |
| June 2005 | -$5.58 M(-30.0%) | -$993.00 K(-65.5%) | -$5.58 M(+5.0%) |
| Mar 2005 | - | -$2.88 M(+325.3%) | -$5.32 M(-35.2%) |
| Dec 2004 | - | -$676.00 K(-34.8%) | -$8.20 M(-0.7%) |
| Sept 2004 | - | -$1.04 M(+42.4%) | -$8.26 M(+3.6%) |
| June 2004 | -$7.97 M(+333.0%) | -$728.00 K(-87.4%) | -$7.97 M(+10.0%) |
| Mar 2004 | - | -$5.76 M(+683.3%) | -$7.24 M(+387.2%) |
| Dec 2003 | - | -$735.00 K(-2.3%) | -$1.49 M(+97.7%) |
| Sept 2003 | - | -$752.00 K | -$752.00 K |
| June 2003 | -$1.84 M | - | - |
FAQ
- What is MEI Pharma annual free cash flow?
- What is the all time high annual FCF for MEI Pharma?
- What is MEI Pharma annual FCF year-on-year change?
- What is MEI Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for MEI Pharma?
- What is MEI Pharma quarterly FCF year-on-year change?
- What is MEI Pharma TTM free cash flow?
- What is the all time high TTM FCF for MEI Pharma?
- What is MEI Pharma TTM FCF year-on-year change?
What is MEI Pharma annual free cash flow?
The current annual FCF of MEIP is -$50.48 M
What is the all time high annual FCF for MEI Pharma?
MEI Pharma all-time high annual free cash flow is $33.36 M
What is MEI Pharma annual FCF year-on-year change?
Over the past year, MEIP annual free cash flow has changed by +$2.04 M (+3.88%)
What is MEI Pharma quarterly free cash flow?
The current quarterly FCF of MEIP is -$11.45 M
What is the all time high quarterly FCF for MEI Pharma?
MEI Pharma all-time high quarterly free cash flow is $69.00 M
What is MEI Pharma quarterly FCF year-on-year change?
Over the past year, MEIP quarterly free cash flow has changed by +$7.04 M (+38.08%)
What is MEI Pharma TTM free cash flow?
The current TTM FCF of MEIP is -$43.44 M
What is the all time high TTM FCF for MEI Pharma?
MEI Pharma all-time high TTM free cash flow is $52.17 M
What is MEI Pharma TTM FCF year-on-year change?
Over the past year, MEIP TTM free cash flow has changed by +$12.73 M (+22.66%)